Envoy Medical Inc./$COCH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Ticker
$COCH
Sector
Primary listing
Employees
42
Headquarters
Website
COCH Metrics
BasicAdvanced
$21M
-
-$1.40
2.20
-
Price and volume
Market cap
$21M
Beta
2.2
52-week high
$1.91
52-week low
$0.74
Average daily volume
5.6M
Financial strength
Current ratio
0.939
Quick ratio
0.669
Long term debt to equity
-95.901
Total debt to equity
-96.564
Interest coverage (TTM)
-11.15%
Profitability
EBITDA (TTM)
-19.455
Gross margin (TTM)
-262.16%
Net profit margin (TTM)
-9,579.28%
Operating margin (TTM)
-8,872.97%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-148.00%
Return on equity (TTM)
100.68%
Valuation
Price to revenue (TTM)
80.403
Price to book
-0.64
Price to tangible book (TTM)
-0.64
Price to free cash flow (TTM)
-0.881
Free cash flow yield (TTM)
-113.48%
Free cash flow per share (TTM)
-1.004
Growth
Revenue change (TTM)
-26.49%
Earnings per share change (TTM)
30.49%
COCH News
AllArticlesVideos
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfile Corp4 days ago
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfile Corp6 days ago
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
Newsfile Corp7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Envoy Medical Inc. stock?
Envoy Medical Inc. (COCH) has a market cap of $21M as of October 14, 2025.
What is the P/E ratio for Envoy Medical Inc. stock?
The price to earnings (P/E) ratio for Envoy Medical Inc. (COCH) stock is 0 as of October 14, 2025.
Does Envoy Medical Inc. stock pay dividends?
No, Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders as of October 14, 2025.
When is the next Envoy Medical Inc. dividend payment date?
Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders.
What is the beta indicator for Envoy Medical Inc.?
Envoy Medical Inc. (COCH) has a beta rating of 2.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.